Medreich Fexofenadine

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Fexofenadine hydrochloride 120mg;  

Commercializzato da:

Medreich New Zealand Limited

INN (Nome Internazionale):

Fexofenadine hydrochloride 120 mg

Dosaggio:

120 mg

Forma farmaceutica:

Film coated tablet

Composizione:

Active: Fexofenadine hydrochloride 120mg   Excipient: Colloidal silicon dioxide Croscarmellose sodium Hypromellose E-5 Opadry pink 00A94480 Macrogol 6000 Magnesium stearate Mannitol   Silicified microcrystalline cellulose

Tipo di ricetta:

Pharmacy only

Prodotto da:

Virupaksha Organics Pvt. Ltd.

Indicazioni terapeutiche:

Relief of symptoms associated with seasonal allergic rhinitis in adults and children aged 12 years or older

Dettagli prodotto:

Package - Contents - Shelf Life: Blister pack, PVC/PE/ACLAR or PVC/PVdC/Al - 10 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PE/ACLAR or PVC/PVdC/Al - 20 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PE/ACLAR or PVC/PVdC/Al - 30 tablets - 36 months from date of manufacture stored at or below 30°C

Data dell'autorizzazione:

2016-01-22